Consolidation Therapy with Subcutaneous (SC) Alemtuzumab Results in Severe Infectious Toxicity in Previously Untreated CLL Patients Who Achieve a Complete Response (CR) after Fludarabine and Rituximab (FR) Induction Therapy: Interim Safety Analysis of the CALGB Study 10101
- Citation:
- Blood vol 110 (11) 755
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 228
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- T. S. Lin K. A. Donohue M. S. Lucas J. C. Byrd E. M. Bengtson B. L. Peterson R. A. Larson
- Networks:
- Study
- CALGB-10101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: